Literature DB >> 9058653

A dysfunctional allele of the mannose binding protein gene associates with systemic lupus erythematosus in a Spanish population.

E J Davies1, L S Teh, J Ordi-Ros, N Snowden, M C Hillarby, A Hajeer, R Donn, P Perez-Pemen, M Vilardell-Tarres, W E Ollier.   

Abstract

OBJECTIVE: To determine dysfunctional mannose binding protein (MBP) status of Spanish patients with systemic lupus erythematosus (SLE) and to determine whether MBP and complement C4 null alleles contribute in an additive way to SLE susceptibility.
METHODS: The frequencies of MBP alleles (characterized by polymorphisms at codon 54 and codon 57 of exon 1) were determined by the amplification refractory mutation system-polymerase chain reaction in 50 Spanish patients with SLE and 49 matched controls. Mutant genotypes for the codon 54 mutation were confirmed using a Ban I restriction enzyme digest method. Complement C4 allotyping was achieved by agarose gel electrophoresis of neuraminidase/carboxypeptidase B digested plasma samples followed by immunofixation and staining.
RESULTS: At least one dysfunctional MBP allele, unable to activate complement, was present in 52% of patients with SLE and in 31% of controls (OR = 2.4, 95% CI 1.1-5.6). Complement C4 null alleles (either C4A or C4B) were present in 61% of patients and 43% of controls (OR = 2.1, 95% CI 0.9-4.9). A dysfunctional MBP allele and C4 null allele were present in 41% of patients and 16% of controls (OR = 3.2, 95% CI 1.2-8.1).
CONCLUSION: The presence of a dysfunctional MBP allele is a risk factor for developing SLE in this Spanish population and may affect susceptibility in an additive way with C4 null alleles.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9058653

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  17 in total

Review 1.  Genetics and systemic lupus erythematosus.

Authors:  B P Tsao; J M Grossman
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

Review 2.  Complement genetics, deficiencies, and disease associations.

Authors:  Karine R Mayilyan
Journal:  Protein Cell       Date:  2012-07-10       Impact factor: 14.870

Review 3.  New insights into the pathogenesis of systemic lupus erythematosus.

Authors:  Vasileios C Kyttaris; Christina G Katsiari; Yuang-Taung Juang; George C Tsokos
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

4.  Mannan-binding lectin and complement C4A in Icelandic multicase families with systemic lupus erythematosus.

Authors:  S Saevarsdottir; H Kristjansdottir; G Grondal; T Vikingsdottir; K Steinsson; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

5.  Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis.

Authors:  P Garred; T Pressler; H O Madsen; B Frederiksen; A Svejgaard; N Høiby; M Schwartz; C Koch
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 6.  Protective molecules--C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity.

Authors:  Martine Szyper Kravitz; Milena Pitashny; Yehuda Shoenfeld
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

Review 7.  An update on genetic studies of systemic lupus erythematosus.

Authors:  Betty P Tsao
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

8.  Functional variants in MBL2 are associated with type 2 diabetes and pre-diabetes traits in Pima Indians and the old order Amish.

Authors:  Yunhua L Muller; Robert L Hanson; Li Bian; Janel Mack; Xiaolian Shi; Ruth Pakyz; Alan R Shuldiner; William C Knowler; Clifton Bogardus; Leslie J Baier
Journal:  Diabetes       Date:  2010-06-03       Impact factor: 9.461

9.  Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease.

Authors:  C B Foster; T Lehrnbecher; F Mol; S M Steinberg; D J Venzon; T J Walsh; D Noack; J Rae; J A Winkelstein; J T Curnutte; S J Chanock
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

10.  Autoantibodies against mannose-binding lectin in systemic lupus erythematosus.

Authors:  M A Seelen; L A Trouw; J W A van der Hoorn; F C Fallaux-van den Houten; T W J Huizinga; M R Daha; A Roos
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.